Anti-Lipoteichoic acid [BSYX-A110 (Pagibaximab)]
Product Sizes
1 mg
AB02032-10-0-BT-1MG
About this Product
- SKU:
- AB02032-10-0-BT
- Additional Names:
- LTA; Staphylococcus epidermidis lipoteichoic acid
- Application:
- ELISA
- Buffer:
- PBS
- translate.label.attr.clone:
- BSYX-A110 (Pagibaximab)
- Clonality:
- Recombinant Monoclonal
- Extra Details:
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.
- Formulation:
- PBS only.
- Host:
- Human
- Immunogen:
- The original antibody was generated by immunizing mice with whole bacteria strain Hay Streptococcus epidermidis.
- Isotype:
- IgG1
- Purification:
- Purified
- Reactivities:
- Bacteria
- Shipping Conditions:
- Blue Ice
- Specificity:
- This antibody targets the lipoteichoic acid (LTA) which is a major cell wall component of gram positive bacteria. LTA plays an important role in the initiation and progression of bacterial infection, inflammation, and septic shock. This antibody is also reported to bind whole bacteria for e.g. S. epidermidis (types I, II & III), S. hemolyticus, S. hominus, and two serotypes of S. aureus but not to
- Storage Conditions:
- 2-8[o]C, -20[o]C aliquoted. Avoid freeze/thaw cycles.
- Supplier:
- Absolute Antibody
- Type:
- Antibody: Recombinant Antibodies
- Manufacturer's Data Sheet:Ab02032-10.0-BT
